News Headlines

  1. FDA Approves First Cancer Treatment For Any Solid Tumor With A Specific Genetic Feature

    The U.S. Food and Drug Administration recently granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

  2. Cambrex Invests To Increase Pilot Scale API Capacity At Its High Point, NC Facility

    Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently announced that it is to expand pilot plant capabilities at its High Point, NC facility with the installation of a fourth reactor suite.

  3. Thermo Fisher Scientific To Acquire Patheon, A Leading Contract Development And Manufacturing Organization (CDMO)

    Thermo Fisher Scientific Inc., the world leader in serving science, and Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, recently announced that their boards of directors have approved Thermo Fisher’s acquisition of Patheon.

  4. Outsourced Pharma Announces San Diego Forum Agenda Following Successful Boston Event

    Outsourced Pharma announced the agenda for its San Diego event at the conclusion of its Boston conference held this past April. An Early Start on Drug Development and Manufacturing Outsourcing is scheduled for August 22-23 at the Hyatt Regency La Jolla. The complete agenda and list of panelists can be found here.

  5. AMRI Receives NIH Contract Award For Drug Substance Development And Manufacturing Services

    AMRI (NASDAQ: AMRI) today announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for drug substance development and manufacturing services

  6. Pharmatek Adds Further cGMP Spray Drying Capacity In Response To Demand For Improved Pharmaceutical Solubility

    Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that it is increasing spray drying capacity at its Pharmatek, San Diego, California facility with the installation of an additional GEA Niro Mobile Minor™ unit.

  7. Recipharm Opens New GMP Suite For Clinical Trial Material

    Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA.

  8. Pelican BioThermal Awarded United Kingdom’s Most Distinguished Business Honor
  9. Recipharm Delivers First Serialised Batch To Saudi Arabia

    Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017.

  10. $100m+ ‘Medical Discovery Tower’ In Israel Set To Become Global Powerhouse For Biotech & Health Sciences

    University of Haifa and Rambam Healthcare Campus yesterday unveiled a strategic partnership and plans to develop a $100M plus, twenty-story ‘Medical Discovery Tower’ during a special ceremony in Haifa, Israel in the presence of the Israeli Health Minister and Finance Minister.